Short Interest in BioRestorative Therapies, Inc. (NASDAQ:BRTX) Decreases By 10.1%

BioRestorative Therapies, Inc. (NASDAQ:BRTX) was the recipient of a significant decline in short interest in November. As of November 30th, there was short interest totalling 66,900 shares, a decline of 10.1% from the November 15th total of 74,400 shares. Based on an average trading volume of 50,000 shares, the days-to-cover ratio is currently 1.3 days. Currently, 1.3% of the company’s stock are short sold.

BioRestorative Therapies Price Performance

Shares of BioRestorative Therapies stock traded down $0.01 during trading hours on Tuesday, hitting $1.45. 8,082 shares of the company’s stock traded hands, compared to its average volume of 707,364. The company has a fifty day simple moving average of $1.55 and a 200-day simple moving average of $1.62. BioRestorative Therapies has a 12-month low of $1.03 and a 12-month high of $3.67. The stock has a market capitalization of $10.04 million, a price-to-earnings ratio of -0.95 and a beta of 62.52.

BioRestorative Therapies (NASDAQ:BRTX) last posted its quarterly earnings data on Tuesday, November 12th. The company reported ($0.13) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.35) by $0.22. BioRestorative Therapies had a negative return on equity of 98.49% and a negative net margin of 2,697.08%. The firm had revenue of $0.23 million during the quarter, compared to analysts’ expectations of $0.30 million. On average, analysts forecast that BioRestorative Therapies will post -1.43 EPS for the current fiscal year.

BioRestorative Therapies Company Profile

BioRestorative Therapies, Inc, a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders.